401k Plan data: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN plan

BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 401k Plan overview

Plan Name	BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN
Plan identification number	004

BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Age/Service Weighted or new comparability or similar plan - Age/Service Weighted Plan: Allocations are based on age, service, or age and service. New comparability or similar plan: Allocations are based on participant classifications and a classification(s) consists entirely or predominantly of highly compensated employees; or the plan provides an additional allocation rate on compensation above a specified threshold, and the theshold or additional rate exceeds the maximum threshold or rate allowed under the permitted disparity rules of section 401(l).
Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Partial participant-directed account plan - Participants have the opportunity to direct the investment of a portion of the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Participant-directed brokerage accounts provided as an investment option under the plan.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

BALBOA NEPHROLOGY MEDICAL GROUP INC has sponsored the creation of one or more 401k plans.

Company Name: BALBOA NEPHROLOGY MEDICAL GROUP INC

Employer identification number (EIN): 952848091

NAIC Classification: 621111
NAIC Description: Offices of Physicians (except Mental Health Specialists)

Additional information about BALBOA NEPHROLOGY MEDICAL GROUP INC

Jurisdiction of Incorporation: California Department of State

Incorporation Date: 1973-08-01

Company Identification Number: C0686489

Legal Registered Office Address: 9610 Granite Ridge Dr., #B

San Diego
United States of America (USA)
92123

More information about BALBOA NEPHROLOGY MEDICAL GROUP INC

Form 5500 Filing Information

Submission information for form 5500 for 401k plan BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
004 2022-01-01
004 2021-01-01 SHAUN EDELSTEIN 2022-09-26
004 2020-01-01 SHAUN EDELSTEIN 2021-09-14
004 2019-01-01 SHAUN EDELSTEIN 2020-10-11
004 2018-01-01 SHAUN EDELSTEIN 2019-10-10
004 2017-01-01
004 2016-01-01
004 2015-01-01 SHAUN EDELSTEIN 2016-10-10
004 2014-01-01 SHAUN EDELSTEIN 2015-08-14 SHAUN EDELSTEIN 2015-08-14
004 2013-01-01 SHAUN EDELSTEIN 2014-08-19 SHAUN EDELSTEIN 2014-08-19
004 2012-01-01 SHAUN EDELSTEIN 2013-09-27 SHAUN EDELSTEIN 2013-09-27
004 2011-01-01 SHAUN EDELSTEIN 2012-10-05 SHAUN EDELSTEIN 2012-10-05
004 2010-01-01 SHAUN EDELSTEIN SHAUN EDELSTEIN 2011-09-30
004 2009-01-01 SHAUN EDELSTEIN SHAUN EDELSTEIN 2010-09-08

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
004	2022-01-01
004	2021-01-01	SHAUN EDELSTEIN	2022-09-26
004	2020-01-01	SHAUN EDELSTEIN	2021-09-14
004	2019-01-01	SHAUN EDELSTEIN	2020-10-11
004	2018-01-01	SHAUN EDELSTEIN	2019-10-10
004	2017-01-01
004	2016-01-01
004	2015-01-01	SHAUN EDELSTEIN	2016-10-10
004	2014-01-01	SHAUN EDELSTEIN	2015-08-14	SHAUN EDELSTEIN	2015-08-14
004	2013-01-01	SHAUN EDELSTEIN	2014-08-19	SHAUN EDELSTEIN	2014-08-19
004	2012-01-01	SHAUN EDELSTEIN	2013-09-27	SHAUN EDELSTEIN	2013-09-27
004	2011-01-01	SHAUN EDELSTEIN	2012-10-05	SHAUN EDELSTEIN	2012-10-05
004	2010-01-01	SHAUN EDELSTEIN		SHAUN EDELSTEIN	2011-09-30
004	2009-01-01	SHAUN EDELSTEIN		SHAUN EDELSTEIN	2010-09-08

Plan Statistics for BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN

401k plan membership statisitcs for BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN

Measure Date Value
2022: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 245
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 194
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 71
Total of all active and inactive participants 2022-01-01 265
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 265
Number of participants with account balances 2022-01-01 265
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 12
2021: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 261
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 167
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 78
Total of all active and inactive participants 2021-01-01 245
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 245
Number of participants with account balances 2021-01-01 245
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 32
2020: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 240
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 184
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 73
Total of all active and inactive participants 2020-01-01 257
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 257
Number of participants with account balances 2020-01-01 257
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 16
2019: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 200
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 163
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 51
Total of all active and inactive participants 2019-01-01 214
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 214
Number of participants with account balances 2019-01-01 214
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 8
2018: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 183
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 148
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 47
Total of all active and inactive participants 2018-01-01 195
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 195
Number of participants with account balances 2018-01-01 195
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 12
2017: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 168
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 143
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 39
Total of all active and inactive participants 2017-01-01 182
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 182
Number of participants with account balances 2017-01-01 182
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 7
2016: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 133
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 137
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 26
Total of all active and inactive participants 2016-01-01 163
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 163
Number of participants with account balances 2016-01-01 163
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 7
2010: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2010 401k membership
Total participants, beginning-of-year 2010-01-01 90
Total number of active participants reported on line 7a of the Form 5500 2010-01-01 84
Number of retired or separated participants receiving benefits 2010-01-01 0
Number of other retired or separated participants entitled to future benefits 2010-01-01 11
Total of all active and inactive participants 2010-01-01 95
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2010-01-01 1
Total participants 2010-01-01 96
Number of participants with account balances 2010-01-01 96
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2010-01-01 4
2009: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 78
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 75
Number of retired or separated participants receiving benefits 2009-01-01 0
Number of other retired or separated participants entitled to future benefits 2009-01-01 10
Total of all active and inactive participants 2009-01-01 85
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 2
Total participants 2009-01-01 87
Number of participants with account balances 2009-01-01 86
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 1

Measure	Date	Value
2022: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	245
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	194
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	71
Total of all active and inactive participants	2022-01-01	265
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	265
Number of participants with account balances	2022-01-01	265
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	12
2021: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	261
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	167
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	78
Total of all active and inactive participants	2021-01-01	245
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	245
Number of participants with account balances	2021-01-01	245
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	32
2020: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	240
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	184
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	73
Total of all active and inactive participants	2020-01-01	257
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	257
Number of participants with account balances	2020-01-01	257
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	16
2019: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	200
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	163
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	51
Total of all active and inactive participants	2019-01-01	214
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	214
Number of participants with account balances	2019-01-01	214
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	8
2018: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	183
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	148
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	47
Total of all active and inactive participants	2018-01-01	195
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	195
Number of participants with account balances	2018-01-01	195
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	12
2017: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	168
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	143
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	39
Total of all active and inactive participants	2017-01-01	182
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	182
Number of participants with account balances	2017-01-01	182
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	7
2016: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	133
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	137
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	26
Total of all active and inactive participants	2016-01-01	163
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	163
Number of participants with account balances	2016-01-01	163
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	7
2010: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2010 401k membership
Total participants, beginning-of-year	2010-01-01	90
Total number of active participants reported on line 7a of the Form 5500	2010-01-01	84
Number of retired or separated participants receiving benefits	2010-01-01	0
Number of other retired or separated participants entitled to future benefits	2010-01-01	11
Total of all active and inactive participants	2010-01-01	95
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2010-01-01	1
Total participants	2010-01-01	96
Number of participants with account balances	2010-01-01	96
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2010-01-01	4
2009: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	78
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	75
Number of retired or separated participants receiving benefits	2009-01-01	0
Number of other retired or separated participants entitled to future benefits	2009-01-01	10
Total of all active and inactive participants	2009-01-01	85
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	2
Total participants	2009-01-01	87
Number of participants with account balances	2009-01-01	86
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	1

Financial Data on BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN

Measure	Date	Value
2022 : BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2022 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2022-12-31	$-772,107
Total unrealized appreciation/depreciation of assets	2022-12-31	$-772,107
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$-1,716,466
Total loss/gain on sale of assets	2022-12-31	$23,807
Total of all expenses incurred	2022-12-31	$927,497
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$779,380
Value of total corrective distributions	2022-12-31	$881
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$4,212,231
Value of total assets at end of year	2022-12-31	$29,878,836
Value of total assets at beginning of year	2022-12-31	$32,522,799
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$147,236
Total interest from all sources	2022-12-31	$8,314
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$586,484
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$585,232
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$1,265,521
Participant contributions at end of year	2022-12-31	$12,056
Participant contributions at beginning of year	2022-12-31	$24,617
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$496,978
Administrative expenses (other) incurred	2022-12-31	$147,236
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-2,643,963
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$29,878,836
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$32,522,799
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$26,189,511
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$28,808,196
Interest on participant loans	2022-12-31	$989
Value of interest in common/collective trusts at end of year	2022-12-31	$413,251
Value of interest in common/collective trusts at beginning of year	2022-12-31	$11,088
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2022-12-31	$641,538
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2022-12-31	$459,071
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2022-12-31	$459,071
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2022-12-31	$7,325
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-5,778,439
Net investment gain or loss from common/collective trusts	2022-12-31	$3,244
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$2,449,732
Employer contributions (assets) at end of year	2022-12-31	$1,928,081
Employer contributions (assets) at beginning of year	2022-12-31	$1,905,427
Income. Dividends from common stock	2022-12-31	$1,252
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$779,380
Assets. Corporate common stocks other than exployer securities at end of year	2022-12-31	$694,399
Assets. Corporate common stocks other than exployer securities at beginning of year	2022-12-31	$1,314,400
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Aggregate proceeds on sale of assets	2022-12-31	$211,492
Aggregate carrying amount (costs) on sale of assets	2022-12-31	$187,685
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	ALDRICH CPAS & ADVISORS LLP
Accountancy firm EIN	2022-12-31	930623286
2021 : BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2021 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2021-12-31	$-274,953
Total unrealized appreciation/depreciation of assets	2021-12-31	$-274,953
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$7,790,282
Total loss/gain on sale of assets	2021-12-31	$340,425
Total of all expenses incurred	2021-12-31	$11,274,900
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$11,100,391
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$3,783,383
Value of total assets at end of year	2021-12-31	$32,522,799
Value of total assets at beginning of year	2021-12-31	$36,007,417
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$174,509
Total interest from all sources	2021-12-31	$1,585
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$685,484
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$674,504
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$1,222,083
Participant contributions at end of year	2021-12-31	$24,616
Participant contributions at beginning of year	2021-12-31	$32,907
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$1,914
Administrative expenses (other) incurred	2021-12-31	$174,509
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$-3,484,618
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$32,522,799
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$36,007,417
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$28,808,197
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$32,474,023
Interest on participant loans	2021-12-31	$1,520
Value of interest in common/collective trusts at end of year	2021-12-31	$11,088
Value of interest in common/collective trusts at beginning of year	2021-12-31	$448,257
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2021-12-31	$459,071
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2021-12-31	$509,126
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2021-12-31	$509,126
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2021-12-31	$65
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$3,251,500
Net investment gain or loss from common/collective trusts	2021-12-31	$2,858
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$2,559,386
Employer contributions (assets) at end of year	2021-12-31	$1,905,427
Employer contributions (assets) at beginning of year	2021-12-31	$1,805,047
Income. Dividends from common stock	2021-12-31	$10,980
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$11,100,391
Assets. Corporate common stocks other than exployer securities at end of year	2021-12-31	$1,314,400
Assets. Corporate common stocks other than exployer securities at beginning of year	2021-12-31	$738,057
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Aggregate proceeds on sale of assets	2021-12-31	$5,234,618
Aggregate carrying amount (costs) on sale of assets	2021-12-31	$4,894,193
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	ALDRICH CPAS & ADVISORS LLP
Accountancy firm EIN	2021-12-31	930623286
2020 : BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2020 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2020-12-31	$186,568
Total unrealized appreciation/depreciation of assets	2020-12-31	$186,568
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$10,377,322
Total loss/gain on sale of assets	2020-12-31	$16,686
Total of all expenses incurred	2020-12-31	$2,880,267
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$2,731,721
Value of total corrective distributions	2020-12-31	$3,757
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$6,262,434
Value of total assets at end of year	2020-12-31	$36,007,417
Value of total assets at beginning of year	2020-12-31	$28,510,362
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$144,789
Total interest from all sources	2020-12-31	$3,818
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$686,407
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$682,552
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$1,199,050
Participant contributions at end of year	2020-12-31	$32,907
Participant contributions at beginning of year	2020-12-31	$42,777
Participant contributions at beginning of year	2020-12-31	$25,000
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$1,188,461
Administrative expenses (other) incurred	2020-12-31	$144,789
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$7,497,055
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$36,007,417
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$28,510,362
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$32,474,023
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$26,916,331
Interest on participant loans	2020-12-31	$2,051
Value of interest in common/collective trusts at end of year	2020-12-31	$448,257
Value of interest in common/collective trusts at beginning of year	2020-12-31	$441,832
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2020-12-31	$509,126
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2020-12-31	$778,434
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2020-12-31	$778,434
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-12-31	$1,767
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$3,213,301
Net investment gain or loss from common/collective trusts	2020-12-31	$8,108
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$3,874,923
Employer contributions (assets) at end of year	2020-12-31	$1,805,047
Income. Dividends from common stock	2020-12-31	$3,855
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$2,731,721
Assets. Corporate common stocks other than exployer securities at end of year	2020-12-31	$738,057
Assets. Corporate common stocks other than exployer securities at beginning of year	2020-12-31	$305,988
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Aggregate proceeds on sale of assets	2020-12-31	$992,672
Aggregate carrying amount (costs) on sale of assets	2020-12-31	$975,986
Opinion of an independent qualified public accountant for this plan	2020-12-31	Unqualified
Accountancy firm name	2020-12-31	ALDRICH CPAS & ADVISORS LLP
Accountancy firm EIN	2020-12-31	954244393
2019 : BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2019 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2019-12-31	$216,245
Unrealized appreciation/depreciation of other (non real estate) assets	2019-12-31	$216,245
Total unrealized appreciation/depreciation of assets	2019-12-31	$216,245
Total unrealized appreciation/depreciation of assets	2019-12-31	$216,245
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$6,055,797
Total income from all sources (including contributions)	2019-12-31	$6,055,797
Total loss/gain on sale of assets	2019-12-31	$4,241
Total loss/gain on sale of assets	2019-12-31	$4,241
Total of all expenses incurred	2019-12-31	$932,962
Total of all expenses incurred	2019-12-31	$932,962
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$807,485
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$807,485
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$1,534,763
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$1,534,763
Value of total assets at end of year	2019-12-31	$28,510,362
Value of total assets at end of year	2019-12-31	$28,510,362
Value of total assets at beginning of year	2019-12-31	$23,387,527
Value of total assets at beginning of year	2019-12-31	$23,387,527
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$125,477
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$125,477
Total interest from all sources	2019-12-31	$49,921
Total interest from all sources	2019-12-31	$49,921
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$2,414,234
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$2,414,234
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$2,413,950
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$2,413,950
Was this plan covered by a fidelity bond	2019-12-31	Yes
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$1,000,000
Value of fidelity bond cover	2019-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$939,742
Contributions received from participants	2019-12-31	$939,742
Participant contributions at end of year	2019-12-31	$42,777
Participant contributions at end of year	2019-12-31	$42,777
Participant contributions at beginning of year	2019-12-31	$53,462
Participant contributions at beginning of year	2019-12-31	$53,462
Participant contributions at end of year	2019-12-31	$25,000
Participant contributions at end of year	2019-12-31	$25,000
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$29,465
Administrative expenses (other) incurred	2019-12-31	$1,765
Administrative expenses (other) incurred	2019-12-31	$1,765
Total non interest bearing cash at beginning of year	2019-12-31	$1,377
Total non interest bearing cash at beginning of year	2019-12-31	$1,377
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$5,122,835
Value of net income/loss	2019-12-31	$5,122,835
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$28,510,362
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$28,510,362
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$23,387,527
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$23,387,527
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Investment advisory and management fees	2019-12-31	$83,704
Investment advisory and management fees	2019-12-31	$83,704
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$26,916,331
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$26,916,331
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$18,792,273
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$18,792,273
Interest on participant loans	2019-12-31	$2,539
Interest on participant loans	2019-12-31	$2,539
Value of interest in common/collective trusts at end of year	2019-12-31	$441,832
Value of interest in common/collective trusts at end of year	2019-12-31	$441,832
Value of interest in common/collective trusts at beginning of year	2019-12-31	$419,411
Value of interest in common/collective trusts at beginning of year	2019-12-31	$419,411
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$778,434
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$778,434
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$2,679,648
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$2,679,648
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$2,679,648
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$2,679,648
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$47,382
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$47,382
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$1,827,391
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$1,827,391
Net investment gain or loss from common/collective trusts	2019-12-31	$9,002
Net investment gain or loss from common/collective trusts	2019-12-31	$9,002
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	Yes
Was there a failure to transmit to the plan any participant contributions	2019-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$565,556
Contributions received in cash from employer	2019-12-31	$565,556
Employer contributions (assets) at beginning of year	2019-12-31	$1,421,617
Employer contributions (assets) at beginning of year	2019-12-31	$1,421,617
Income. Dividends from common stock	2019-12-31	$284
Income. Dividends from common stock	2019-12-31	$284
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$807,485
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$807,485
Contract administrator fees	2019-12-31	$40,008
Contract administrator fees	2019-12-31	$40,008
Assets. Corporate common stocks other than exployer securities at end of year	2019-12-31	$305,988
Assets. Corporate common stocks other than exployer securities at end of year	2019-12-31	$305,988
Assets. Corporate common stocks other than exployer securities at beginning of year	2019-12-31	$19,739
Assets. Corporate common stocks other than exployer securities at beginning of year	2019-12-31	$19,739
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Aggregate proceeds on sale of assets	2019-12-31	$41,306
Aggregate proceeds on sale of assets	2019-12-31	$41,306
Aggregate carrying amount (costs) on sale of assets	2019-12-31	$37,065
Aggregate carrying amount (costs) on sale of assets	2019-12-31	$37,065
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	ALDRICH CPAS & ADVISORS LLP
Accountancy firm name	2019-12-31	ALDRICH CPAS & ADVISORS LLP
Accountancy firm EIN	2019-12-31	954244393
Accountancy firm EIN	2019-12-31	954244393
2018 : BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2018 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2018-12-31	$-7,601
Total unrealized appreciation/depreciation of assets	2018-12-31	$-7,601
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$9,842,631
Total loss/gain on sale of assets	2018-12-31	$-54,875
Total of all expenses incurred	2018-12-31	$7,429,520
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$7,286,948
Expenses. Certain deemed distributions of participant loans	2018-12-31	$2,959
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$10,770,632
Value of total assets at end of year	2018-12-31	$23,387,527
Value of total assets at beginning of year	2018-12-31	$20,974,416
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$139,613
Total interest from all sources	2018-12-31	$90,249
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$502,486
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$502,486
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$867,147
Participant contributions at end of year	2018-12-31	$53,462
Participant contributions at beginning of year	2018-12-31	$84,375
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$7,964,974
Total non interest bearing cash at end of year	2018-12-31	$1,377
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$2,413,111
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$23,387,527
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$20,974,416
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Investment advisory and management fees	2018-12-31	$102,181
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$18,792,273
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$16,229,320
Income. Interest from loans (other than to participants)	2018-12-31	$3,643
Income. Interest from corporate debt instruments	2018-12-31	$25,436
Value of interest in common/collective trusts at end of year	2018-12-31	$419,411
Value of interest in common/collective trusts at beginning of year	2018-12-31	$213,903
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2018-12-31	$2,679,648
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2018-12-31	$3,326,742
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2018-12-31	$3,326,742
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2018-12-31	$61,170
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-1,464,896
Net investment gain or loss from common/collective trusts	2018-12-31	$6,636
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$1,938,511
Employer contributions (assets) at end of year	2018-12-31	$1,421,617
Employer contributions (assets) at beginning of year	2018-12-31	$1,120,076
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$7,286,948
Contract administrator fees	2018-12-31	$37,432
Assets. Corporate common stocks other than exployer securities at end of year	2018-12-31	$19,739
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Aggregate proceeds on sale of assets	2018-12-31	$1,212,987
Aggregate carrying amount (costs) on sale of assets	2018-12-31	$1,267,862
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	DUFFY KRUSPODIN LLP
Accountancy firm EIN	2018-12-31	954244393
2017 : BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$142
Total income from all sources (including contributions)	2017-12-31	$4,998,392
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$1,673,056
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$1,557,354
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$2,332,665
Value of total assets at end of year	2017-12-31	$20,974,416
Value of total assets at beginning of year	2017-12-31	$17,649,222
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$115,702
Total interest from all sources	2017-12-31	$12,998
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$396,604
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$396,604
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$2,000,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$690,723
Participant contributions at end of year	2017-12-31	$84,375
Participant contributions at beginning of year	2017-12-31	$123,473
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$42,225
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2017-12-31	$142
Other income not declared elsewhere	2017-12-31	$-1,624
Total non interest bearing cash at beginning of year	2017-12-31	$1,056
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$3,325,336
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$20,974,416
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$17,649,080
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$16,229,320
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$10,799,309
Interest on participant loans	2017-12-31	$5,409
Value of interest in common/collective trusts at end of year	2017-12-31	$213,903
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2017-12-31	$3,326,742
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2017-12-31	$1,290,536
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2017-12-31	$1,290,536
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2017-12-31	$7,589
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$2,254,985
Net investment gain or loss from common/collective trusts	2017-12-31	$2,764
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$1,599,717
Employer contributions (assets) at end of year	2017-12-31	$1,120,076
Employer contributions (assets) at beginning of year	2017-12-31	$592,111
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$1,557,354
Contract administrator fees	2017-12-31	$115,702
Assets. Corporate common stocks other than exployer securities at beginning of year	2017-12-31	$4,842,737
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	DUFFY KRUSPODIN, LLP
Accountancy firm EIN	2017-12-31	954244393
2016 : BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2016 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2016-12-31	$40,367
Total unrealized appreciation/depreciation of assets	2016-12-31	$40,367
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$142
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$5,037,069
Total loss/gain on sale of assets	2016-12-31	$213,957
Total of all expenses incurred	2016-12-31	$471,339
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$360,859
Expenses. Certain deemed distributions of participant loans	2016-12-31	$20,895
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$4,182,166
Value of total assets at end of year	2016-12-31	$17,649,222
Value of total assets at beginning of year	2016-12-31	$13,083,350
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$89,585
Total interest from all sources	2016-12-31	$8,654
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$309,704
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$195,947
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$2,000,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$649,900
Participant contributions at end of year	2016-12-31	$123,473
Participant contributions at beginning of year	2016-12-31	$213,900
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$2,478,929
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2016-12-31	$142
Administrative expenses (other) incurred	2016-12-31	$225
Total non interest bearing cash at end of year	2016-12-31	$1,056
Total non interest bearing cash at beginning of year	2016-12-31	$753
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$4,565,730
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$17,649,080
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$13,083,350
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Assets. partnership/joint venture interests at beginning of year	2016-12-31	$255,493
Investment advisory and management fees	2016-12-31	$20,832
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$10,799,309
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$10,858,511
Interest on participant loans	2016-12-31	$8,209
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2016-12-31	$1,290,536
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2016-12-31	$1,049,345
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2016-12-31	$1,049,345
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2016-12-31	$445
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$282,221
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$1,053,337
Employer contributions (assets) at end of year	2016-12-31	$592,111
Employer contributions (assets) at beginning of year	2016-12-31	$458,491
Income. Dividends from common stock	2016-12-31	$113,757
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$360,859
Contract administrator fees	2016-12-31	$68,528
Assets. Corporate common stocks other than exployer securities at end of year	2016-12-31	$4,842,737
Assets. Corporate common stocks other than exployer securities at beginning of year	2016-12-31	$246,857
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Aggregate proceeds on sale of assets	2016-12-31	$6,171,725
Aggregate carrying amount (costs) on sale of assets	2016-12-31	$5,957,768
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	DUFFY KRUSPODIN, LLP
Accountancy firm EIN	2016-12-31	954244393
2010 : BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2010 401k financial data
Total income from all sources	2010-12-31	$1,561,414
Expenses. Total of all expenses incurred	2010-12-31	$285,600
Benefits paid (including direct rollovers)	2010-12-31	$196,203
Total plan assets at end of year	2010-12-31	$9,366,901
Total plan assets at beginning of year	2010-12-31	$8,091,087
Value of fidelity bond covering the plan	2010-12-31	$500,000
Total contributions received or receivable from participants	2010-12-31	$0
Contributions received from other sources (not participants or employers)	2010-12-31	$0
Other income received	2010-12-31	$1,069,493
Net income (gross income less expenses)	2010-12-31	$1,275,814
Net plan assets at end of year (total assets less liabilities)	2010-12-31	$9,366,901
Net plan assets at beginning of year (total assets less liabilities)	2010-12-31	$8,091,087
Assets. Value of participant loans	2010-12-31	$92,276
Total contributions received or receivable from employer(s)	2010-12-31	$491,921
Expenses. Administrative service providers (salaries,fees and commissions)	2010-12-31	$89,397

Form 5500 Responses for BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN

2022: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2010: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2010 form 5500 responses
2010-01-01	Type of plan entity	Single employer plan
2010-01-01	Submission has been amended	No
2010-01-01	This submission is the final filing	No
2010-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2010-01-01	Plan is a collectively bargained plan	No
2010-01-01	Plan funding arrangement – Trust	Yes
2010-01-01	Plan benefit arrangement - Trust	Yes
2009: BALBOA NEPHROLOGY MEDICAL GROUP, INC. PROFIT SHARING PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	BALBOA NEPHROLOGY MEDICAL GROUP INC
Employer identification number (EIN):	952848091
NAIC Classification:	621111
NAIC Description:	Offices of Physicians (except Mental Health Specialists)

Jurisdiction of Incorporation:	California Department of State
Incorporation Date:	1973-08-01
Company Identification Number:	C0686489
Legal Registered Office Address:	9610 Granite Ridge Dr., #B San Diego United States of America (USA) 92123